Navigation Links
Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
Date:3/7/2008

SANTA CLARA, Calif., March 7 /PRNewswire/ -- Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the first TruBio(TM) OS plug-in for OPC connectivity between TruBio(TM) OS and Nova BioProfile 400, 100 Plus, Basic 4 and Basic 2 analyzers. Both companies confirmed that a TruBio(TM) OS plug-in for OPC connectivity to the Nova Flex is currently in development.

OPC (Openness, Productivity and Collaboration) has become the de facto standard for data exchange in process control systems. It has been adopted by the majority of the control system manufacturers in the bioprocess industry and has proven to be a reliable method for sharing information across different hardware platforms.

Automatic data exchange using OPC between a lab analyzer and control system reduces errors and time delays of manual sampling, and provides automated reporting of results. It also allows the control system to adjust process parameters without a 24/7 operator presence, and, in the event of process alarm conditions, alerts off-site personnel and/or takes automatic corrective action.

This level of integration enables direct consolidation of off-line lab analyzer results into existing historical data collection, automates batch report generation, and creates a complete electronic record. Printouts of standalone analyzer results do not have to be manually attached or tracked with electronic batch reports that control systems already provide.

"Taking advantage of OPC connectivity between Nova analyzers and the Finesse bioprocess control system will improve quality and yield, while reducing operating costs. For example, programming a Nova analyzer to automatically standardize an in-situ probe, or using the resulting sample data in real-time control algorithms, will increase both process understanding and control accuracy," stated Dr. Mark Selker, CTO and co-founder of Finesse.

"By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability. The value lies in the actions upon that information. Nova and Finesse provide the compliment to each other's technologies thereby allowing our customers real-time benefits that, until now, were impossible," says Bob Fox, Director of Sales.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com.

About Nova Biomedical

Nova Biomedical is committed to continue its technology leadership with advanced products that provide better, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Finesse Solutions Expands by Opening Sales and Service Centers
2. Finesse Introduces TruBio(TM) IOQ
3. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
4. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
5. Senetek PLC Announces Appointments of Key Personnel
6. Iomai Announces Year-End 2007 Financial Results and Business Progress
7. Dragon announces new product launch; increase in annual production output capacity
8. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
9. China Yingxia International Announces Q4 and FY 2007 Estimates
10. Bristol-Myers Squibb Announces Dividend
11. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... Market with the addition of its newest module, US Hemostats & Sealants. , ... thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):